Home › Funds › PNC Financial Services › ITCI

PNC Financial Services position in ITCI

INTRA-CELLULAR THERAPIES INC

Latest position (Q1 2025)2.52K sh
Reported value held$331.91K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q3 2021 3.23K $121.00K New
Q4 2021 4.71K $246.00K Add
Q1 2022 5.91K $363.00K Add
Q2 2022 5.89K $336.00K Hold
Q3 2022 6.66K $310.00K Add
Q4 2022 5.88K $310.90K Reduce
Q1 2023 6.20K $335.84K Add
Q2 2023 7.13K $451.53K Add
Q3 2023 4.03K $210.13K Reduce
Q4 2023 3.79K $271.80K Reduce
Q1 2024 4.38K $302.96K Add
Q2 2024 7.55K $517.03K Add
Q3 2024 8.39K $613.97K Add
Q4 2024 8.03K $671.00K Reduce
Q1 2025 2.52K $331.91K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding ITCI

No other tracked fund reports a position in ITCI.

All ITCI fund holders →